Evidence mapPaperPMID 26465872Full record

Trial reportArquivos brasileiros de cardiologia2015

Renin-Angiotensin System Blockade Associated with Statin Improves Endothelial Function in Diabetics.

Ronaldo Altenburg Gismondi, Ricardo Bedirian, Cesar Romaro Pozzobon, Márcia Cristina Ladeira, Wille Oigman, Mário Fritsch Neves

Open access · diamondAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Arquivos brasileiros de cardiologia, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Ronaldo Altenburg GismondiUniversidade do Estado do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Ricardo BedirianUniversidade do Estado do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Cesar Romaro PozzobonUniversidade do Estado do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Márcia Cristina LadeiraUniversidade do Estado do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Wille OigmanUniversidade do Estado do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Mário Fritsch NevesUniversidade do Estado do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Hospital Universitário Antônio Pedro · BRUniversidade do Estado do Rio de Janeiro · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundStudies suggest that statins have pleiotropic effects, such as reduction in blood pressure, and improvement in endothelial function and vascular stiffness.

objectiveTo analyze if prior statin use influences the effect of renin-angiotensin-aldosterone system inhibitors on blood pressure, endothelial function, and vascular stiffness.

methodsPatients with diabetes and hypertension with office systolic blood pressure ≥ 130 mmHg and/or diastolic blood pressure ≥ 80 mmHg had their antihypertensive medications replaced by amlodipine during 6 weeks. They were then randomized to either benazepril or losartan for 12 additional weeks while continuing on amlodipine. Blood pressure (assessed with ambulatory blood pressure monitoring), endothelial function (brachial artery flow-mediated dilation), and vascular stiffness (pulse wave velocity) were evaluated before and after the combined treatment. In this study, a post hoc analysis was performed to compare patients who were or were not on statins (SU and NSU groups, respectively).

resultsThe SU group presented a greater reduction in the 24-hour systolic blood pressure (from 134 to 122 mmHg, p = 0.007), and in the brachial artery flow-mediated dilation (from 6.5 to 10.9%, p = 0.003) when compared with the NSU group (from 137 to 128 mmHg, p = 0.362, and from 7.5 to 8.3%, p = 0.820). There was no statistically significant difference in pulse wave velocity (SU group: from 9.95 to 9.90 m/s, p = 0.650; NSU group: from 10.65 to 11.05 m/s, p = 0.586).

conclusionCombined use of statins, amlodipine, and renin-angiotensin-aldosterone system inhibitors improves the antihypertensive response and endothelial function in patients with hypertension and diabetes.

Indexed as

Amino AcidsAmlodipineAngiotensin-Converting Enzyme InhibitorsAntihypertensive AgentsBenzazepinesBlood PressureBlood Pressure Monitoring, AmbulatoryBrachial ArteryDiabetes Mellitus, Type 2Endothelium, VascularFemaleHumansHypertensionLosartanMaleMiddle AgedAmino AcidsAmlodipineAngiotensin-Converting Enzyme InhibitorsAntihypertensive AgentsbenazeprilBenzazepinesLosartanstatine

Identifiers

PMID26465872
PMCPMC4693664
OpenAlexW2262216087

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.